WeVote
Log In

Bill

Bill

SB 842

Establishes "Cindi's Law" requiring certain diagnostic tests for uterine cancer

2026 Regular Session Introduced by Mike Bernskoetter

Missouri bill mandates specific uterine cancer diagnostic tests to improve detection consistency and early-stage identification across healthcare providers.

0
WeVote Research Nonpartisan
Bill Summary · SB 842

Legislative bill overview

SB 842, known as "Cindi's Law," establishes requirements for certain diagnostic tests related to uterine cancer detection and diagnosis in Missouri. The bill mandates specific testing protocols, though the exact diagnostic procedures and their scope are not detailed in the available legislative record. This appears to be a healthcare quality and patient protection measure named after an individual case.

Why is this important

Uterine cancer is one of the most common gynecologic cancers in the United States, with early detection significantly improving survival rates. Mandating specific diagnostic standards could improve consistency in cancer detection across healthcare providers and potentially catch cases earlier. However, the real-world impact depends heavily on which tests are required, their cost, and whether they represent evidence-based best practices or address gaps in current care.

Potential points of contention

  • Medical necessity vs. mandate: Whether legislatively mandated tests align with current medical guidelines and if they could lead to overutilization or unnecessary procedures
  • Healthcare cost implications: Mandatory diagnostic requirements increase healthcare expenses, potentially affecting insurance premiums and patient out-of-pocket costs
  • Clinical discretion: Rigid testing requirements may limit physicians' ability to tailor diagnostics to individual patient circumstances and clinical presentations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.